← Back to signals
AMGN
BUYAmgen Inc.
Health Care
0.87
PEGY ratio
Rank #131
Why This Matters
This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 63.4% annually over 5 years. Pays a 2.9% dividend yield.
AMGN trades at 24.2x earnings against 25.0% capped growth (actual 63.4%) + 2.9% yield (PEGY 0.87). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 63.4%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-17
Valuation
24.2x
P/E Ratio
Growth
63.4%
5yr EPS
Income
2.9%
Div Yield
PEGY Components
PEGY Score0.87
Denominator27.9%
EPS (TTM)$14.37
Market Data
Price$347.84
ExchangeNASDAQ
S&P 500Nasdaq 100Dow 30
What Changed
PEGY Score
0.86→0.87(+0.01)
Rank
#134→#131(+3 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only